Peng Qin
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)CAR-T cell therapy research (5 papers)Immune Cell Function and Interaction (5 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsBiochemical and Biophysical Research Communications
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Peng Qin
34 papers receiving 500 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 164
- Oncology 148
- Immunology 120
- Cancer Research 96
- Surgery 54
Countries citing papers authored by Peng Qin
This map shows the geographic impact of Peng Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Qin more than expected).
Fields of papers citing papers by Peng Qin
This network shows the impact of papers produced by Peng Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Qin. The network helps show where Peng Qin may publish in the future.
Co-authorship network of co-authors of Peng Qin
This figure shows the co-authorship network connecting the top 25 collaborators of Peng Qin. A scholar is included among the top collaborators of Peng Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Qin. Peng Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 19 | |
| 7 | 9 | |
| 8 | 3 | |
| 9 | 9 | |
| 10 | 9 | |
| 11 | 4 | |
| 12 | 21 | |
| 13 | 20 | |
| 14 | 23 | |
| 15 | 6 | |
| 16 | 37 | |
| 17 | 21 | |
| 18 | 37 | |
| 19 | Efficiency and safety of daclatasvir in treatment of chronic hepatitis C: A meta-analysis | 1 |
| 20 | 17 |
About Peng Qin
Peng Qin is a scholar working on Oncology, Hepatology and Biochemistry, having authored 38 papers that have together received 503 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Cancer Research (96 citations), Immunology (120 citations) and Oncology (148 citations). Peng Qin has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Benling Xu, Quanli Gao, Tiepeng Li, Lu Han, Long Yuan, Peng Yuan, Peng Zhao, Long Wu, Weijia Fang and Junna Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.